1 line
5.2 KiB
JSON
1 line
5.2 KiB
JSON
{"Abdominal abscess": 39.64266638877553, "Abnormal behaviour": 3.433742445346988, "Acute lymphocytic leukaemia": 28.993445463826863, "Acute myeloid leukaemia": 5.891836545351418, "Acute respiratory distress syndrome": 3.196000370771182, "Amyloidosis": 25.58679349938668, "Anaemia": 2.41810699861508, "Ascites": 3.767389091003765, "Aspergillus infection": 6.431472475851303, "Atelectasis": 13.363535612506402, "Bacteraemia": 6.7030803846941245, "Bacterial sepsis": 13.62871952846341, "Brain fog": 3.80838561950461, "Brain oedema": 5.656948749195101, "Bronchopulmonary aspergillosis": 10.512663891943696, "Candida infection": 10.194915393785427, "Cardiac failure": 3.0462653870219114, "Cardiac failure acute": 4.202158128334568, "Cardiogenic shock": 8.686976265927408, "Cardiotoxicity": 6.771867693294144, "Clostridium difficile infection": 5.863781155191644, "Cystitis haemorrhagic": 6.279403976036073, "Cytokine release syndrome": 3.2098951539082066, "Cytomegalovirus chorioretinitis": 18.99505866791836, "Cytomegalovirus infection": 4.08196517042233, "Cytomegalovirus infection reactivation": 24.95663672358785, "Cytopenia": 18.857400337373917, "Device related infection": 5.462717866926816, "Device related sepsis": 27.551091710468608, "Disease progression": 6.684018804310865, "Disease recurrence": 2.891754458033989, "Disseminated intravascular coagulation": 2.0245072744810626, "Disturbance in social behaviour": 32.96847395438122, "Drug ineffective": 2.09721530765359, "Drug ineffective for unapproved indication": 3.450920059997697, "Drug intolerance": 2.3158942234438435, "Drug reaction with eosinophilia and systemic symptoms": 2.7223125418741123, "Drug resistance": 4.24769533979567, "Effusion": 76.38988928367591, "Empyema": 50.05658309470043, "Enterococcal infection": 34.52327111328297, "Escherichia bacteraemia": 22.56597035148707, "Febrile neutropenia": 8.091478180854834, "Functional gastrointestinal disorder": 30.08609264414136, "Graft versus host disease": 6.88856001544937, "Graft versus host disease in gastrointestinal tract": 12.998549725714092, "Haematotoxicity": 5.014086440832481, "Haemophagocytic lymphohistiocytosis": 3.8214682307629415, "Hemianopia": 25.0625688570322, "Hepatitis B reactivation": 29.34498032691541, "Human metapneumovirus test positive": 897.7776851889981, "Human polyomavirus infection": 80.96896438242086, "Hypercalcaemia": 7.89263979461127, "Hypocalcaemia": 3.996073076073188, "Hypogammaglobulinaemia": 24.2398337978363, "Hypoperfusion": 110.2097281671077, "Ileus paralytic": 8.055542746336965, "Infection": 3.4626762145622023, "Infection reactivation": 35.04204649299487, "Infusion related reaction": 2.0796688567753985, "Intentional product use issue": 2.995250424325476, "Klebsiella infection": 33.79957877498846, "Liver disorder": 2.8775596145840594, "Lower respiratory tract infection": 2.107260136192868, "Lymphopenia": 6.087349356498266, "Malignant neoplasm progression": 2.1469346685459314, "Metapneumovirus infection": 102.2879728018637, "Morganella infection": 284.2395129934279, "Mucosal inflammation": 10.07119456556988, "Multiple organ dysfunction syndrome": 5.786790440888698, "Myelodysplastic syndrome": 10.459418173903924, "Myelosuppression": 5.9212924305736, "Neuralgia": 2.86210752542952, "Neuropathy peripheral": 12.61466380877108, "Neurotoxicity": 5.8134152823756295, "Neutropenia": 5.877097924757188, "Off label use": 3.1336815145017183, "Osteonecrosis of jaw": 6.0937859417738895, "Pancytopenia": 4.806276840060104, "Paranoia": 7.083730416430863, "Peripheral sensory neuropathy": 26.60243216122796, "Plasma cell leukaemia": 202.4132823908067, "Plasma cell myeloma": 123.95715837787353, "Plasma cell myeloma recurrent": 184.7513470758042, "Plasma cell myeloma refractory": 690.6130652070248, "Plasmacytoma": 139.77245146240406, "Platelet count decreased": 2.2168492408265026, "Pneumonia": 2.9477583260172757, "Pneumonia bacterial": 8.285454616131386, "Polyneuropathy": 25.32014122752416, "Polyomavirus-associated nephropathy": 72.14547868530732, "Poor quality sleep": 5.6455309832841865, "Posterior reversible encephalopathy syndrome": 17.30020423427628, "Product use in unapproved indication": 3.144487117850824, "Progressive multifocal leukoencephalopathy": 33.05804275521204, "Pulmonary hypertension": 2.7486597628446803, "Pulmonary oedema": 4.260994729700002, "Pulseless electrical activity": 36.52636557711005, "Respiratory failure": 2.3611077501492828, "Respiratory tract infection": 3.701934198328236, "Second primary malignancy": 6.2689706562796434, "Sepsis": 5.25327860096637, "Septic shock": 4.768354365269039, "Shock": 3.456845078529644, "Staphylococcal bacteraemia": 55.40116470785328, "Staphylococcal infection": 3.462095060056636, "Staphylococcal sepsis": 19.992138842365183, "Therapeutic product effect incomplete": 5.205485490624876, "Therapeutic response decreased": 4.563276934575213, "Therapy non-responder": 10.52608279075717, "Therapy partial responder": 31.07916673348921, "Thrombocytopenia": 5.308667594084201, "Thrombotic microangiopathy": 16.775965057481343, "Thrombotic thrombocytopenic purpura": 12.185058020817925, "Treatment failure": 4.093463112350973, "Tumour lysis syndrome": 25.30212047094461, "Upper gastrointestinal haemorrhage": 5.4753576457324655, "Varicella zoster virus infection": 16.88964894513963, "Vascular device infection": 20.45438759252028} |